Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on October 17, 2025
OmniRx Report Finds Patient Demand for Specialized Telehealth Services Has Doubled
Data analysis from the national telehealth provider reveals a significant trend towards virtual consultations for personalized, long-term wellness planning. TAMPA, FL, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- OmniRx Health, a national …
Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown
Massive Bio urges Congress to protect ClinicalTrials.gov as essential infrastructure after its shutdown, ensuring patients can access clinical trial options. BOCA RATON, FL, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- During the ongoing …
Dr. Gold’s Wellness University Launches in Tampa: Where Longevity and Joy Unite!
TAMPA, FL, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- Wellness, vitality and joy come together this fall as Dr. Gold’s Wellness University celebrates its official Launch Party on Saturday, November 1 from 3–6 p.m. at the Saint Leo University …
World Menopause Day Highlights the Need for Functional Nutrition-Based Care for Women in Midlife
Holistic Health Solutions encourages practitioners to embrace lifestyle medicine and functional nutrition as essential tools for menopause support CLEARWATER, FL, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- As the world marks World Menopause …
Allstate Medical Installations Launches National Program to Ensure NFPA 99 Compliance for Medical-Gas Hose Replacement
Supporting Healthcare Facilities in Meeting Safety Standards and Maintaining Accreditation CLEARWATER, FL, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- Allstate Medical Industry Installations Launches National Program to Ensure NFPA 99 …
Nurse Next Door Program Launches FAQ Page for Homebuyer Grants and Assistance
New resource provides step-by-step guidance for nurses looking to buy a home through grants, down payment assistance, and simplified lending programs. TAMPA BAY, FL, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- The Nurse Next Door Program, the …
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA nephropathy JADE101 is an investigational, potentially best-in-class disease-modifying anti-APRIL monoclonal antibody, with …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
SOUTH SAN FRANCISCO, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 15, 2025 it granted stock options to purchase an aggregate of 109,120 shares of common stock and 73,535 restricted …
Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
Boston, Oct. 17, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Targeted Alpha Therapies for Cancer Treatment: Global Market” was valued at $199.6 million in 2024, and is expected to grow at a CAGR of 44% during the period 2025 …
ORYZON Receives Feedback From the FDA in Response to the Submitted Phase III Protocol in Borderline Personality Disorder
Provides clarity on the aspects to incorporate Company to address them and resubmit revised protocol MADRID, Spain and CAMBRIDGE, Mass., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, BME: ORY), a clinical-stage …
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
- Amendment includes finalized cash amount and updated CVR terms for tender offer - LAVA announces new date for extraordinary general meeting of shareholders EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Penn., Oct. 17, 2025 (GLOBE …
Wake Radiology Grows Breast Imaging Section with Five New Hires; Launches "We See the Difference" Campaign for Breast Cancer Awareness Month
Raleigh, N.C., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex, the largest outpatient imaging provider in the Triangle, today announced the continued expansion of its breast imaging section with the addition of five new board-certified …
Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer
BERKELEY, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced the appointment of Gregory D. Kunst as chief executive officer and member of the board of directors. …
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Company announcement – No. 22 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, October 17, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …
Dr. Alyssa Dweck Shares Menopause Insights and Solutions on YourUpdateTV
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- October is Menopause Awareness Month. Nearly half the population will go through it, yet menopause remains one of the most under-discussed health stages for women. During a recent satellite media tour in …
Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke
Novel mechanism of action reverses and prevents death of injured cells Phase II ARPEGGIO trial fully enrolled Topline results to be presented at the World Stroke Congress, October 23, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- …
Artios Announces Phase 1/2a Data for DNA Polymerase Theta Inhibitor ART6043 at ESMO Congress 2025
Potential first-in-class, and industry-leading DNA polymerase Theta (Polθ) inhibitor, ART6043 demonstrated an attractive tolerability profile, expected PK/PD activity, and promising clinical signals Results support the potential advancement of ART6043 into …
Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
Ingelheim, Germany / Ridgefield, Connecticut, U.S. Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC were presented for the first time at ESMO 2025. Confirmed response by …